Vanguard Group’s Cadrenal Therapeutics CVKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$586K Buy
48,595
+2,962
+6% +$35.7K ﹤0.01% 3884
2025
Q1
$805K Buy
+45,633
New +$805K ﹤0.01% 3775